Table 1 Characteristics of publications on benzodiazepine and Z-drug discontinuation in community dwelling adults
From: Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
| Characteristic | No. | % of 139 articles |
|---|---|---|
| Type of article | ||
| Original research | ||
| Randomized-controlled trial | 52 | 37.4 % |
| Before-after study | 8 | 5.8 % |
| Nonrandomized controlled trial | 6 | 4.3 % |
| Systematic review/meta-analysis | 3 | 2.2 % |
| Prospective cohort study | 2 | 1.4 % |
| Non-comparative study | 2 | 1.4 % |
| Retrospective cohort study | 1 | 0.7 % |
| Non-original research | ||
| Narrative review | 58 | 41.7 % |
| Guideline | 7 | 5.0 % |
| Country of origin | ||
| United States | 38 | 27.3 % |
| United Kingdom | 33 | 23.7 % |
| Europe | 24 | 17.3 % |
| Canada | 20 | 14.4 % |
| Australia | 13 | 9.4 % |
| Asia | 2 | 1.4 % |
| Other | 9 | 6.5 % |
| Year of publication | ||
| <1985 | 4 | 2.9 % |
| 1985–1994 | 50 | 36.0 % |
| 1995–2004 | 40 | 28.8 % |
| 2005–2015 | 45 | 32.4 % |
| Primary medical condition | ||
| Mixed | 73 | 52.5 % |
| Anxiety disorders | 27 | 19.4 % |
| Insomnia | 23 | 16.5 % |
| Panic disorders | 16 | 11.5 % |